Issue 40, 2023

Trinuclear rhenium(i)-based metallocages as anticancer agents towards human cervical cancer cells

Abstract

The first examples of spherical-shaped trinuclear rhenium(I) organometallic cages displaying cytotoxic, antimetastatic, antiproliferative and DNA-damaging behavior towards a human cervical (HeLa) cancer cell line are reported. The compact design of the metallocages facilitates their interactions with biosystems leading to comparable efficiency to that of the commonly used anticancer drug cisplatin.

Graphical abstract: Trinuclear rhenium(i)-based metallocages as anticancer agents towards human cervical cancer cells

Supplementary files

Article information

Article type
Communication
Submitted
05 Aug 2023
Accepted
27 Sep 2023
First published
27 Sep 2023

Dalton Trans., 2023,52, 14314-14318

Trinuclear rhenium(I)-based metallocages as anticancer agents towards human cervical cancer cells

M. Kedia, S. Khatun, U. Phukon, B. Shankar, A. K. Rengan and M. Sathiyendiran, Dalton Trans., 2023, 52, 14314 DOI: 10.1039/D3DT02535G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements